CME Group Inc. (CME)
NASDAQ: CME · IEX Real-Time Price · USD
212.59
-4.18 (-1.93%)
At close: Apr 24, 2024, 4:00 PM
212.76
+0.17 (0.08%)
After-hours: Apr 24, 2024, 7:22 PM EDT

Company Description

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.

It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services.

In addition, the company offers a range of market data services, including real-time and historical data services.

It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks.

The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007.

The company was founded in 1898 and is headquartered in Chicago, Illinois.

CME Group Inc.
CME Group logo
Country United States
Founded 1898
IPO Date Dec 6, 2002
Industry Financial Data & Stock Exchanges
Sector Financials
Employees 3,565
CEO Terrence A. Duffy

Contact Details

Address:
20 S. Wacker Dr.
Chicago, Illinois 60606
United States
Phone (312) 930-1000
Website cmegroup.com

Stock Details

Ticker Symbol CME
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001156375
CUSIP Number 12572Q105
ISIN Number US12572Q1058
Employer ID 36-4459170
SIC Code 6200

Key Executives

Name Position
Terrence A. Duffy Chairman and Chief Executive Officer
Lynne Fitzpatrick Chief Financial Officer
Julie Holzrichter Senior MD and Chief Operating Officer
Sunil Cutinho Chief Information Officer
Derek Sammann Senior MD and Global Head of Commodities, Options Products and International Markets
Jack Tobin MD and Chief Accounting Officer
John C. Peschier Managing Director of Investor Relations
Jonathan L. Marcus Senior MD and General Counsel
Anita Liskey Senior Managing Director of Corporate Marketing and Communications
Hilda Harris Piell Senior MD and Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Apr 24, 2024 8-K Current Report
Mar 21, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 19, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 19, 2024 ARS Filing
Mar 18, 2024 DEF 14A Other definitive proxy statements
Mar 7, 2024 8-K Current Report
Feb 28, 2024 10-K Annual Report
Feb 14, 2024 8-K Current Report
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 26, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals